Dr Max Emmerich
@maxemmerichderm.bsky.social
MRC Clinical PhD fellow @TurajlicLab @crick.ac.uk & @ICR_London. Derm Reg St. John’s Institute of Dermatology.
Interested in all things immunology and complex med derm.
👨🔬Mechanisms and biomarkers of #Immunotherapy toxicity and response.
Interested in all things immunology and complex med derm.
👨🔬Mechanisms and biomarkers of #Immunotherapy toxicity and response.
We use ultra high dimensional spectral cytometry coupled with machine learning assisted analytics to generate immune signatures predictive of IO outcomes.
We can also map out longitudinal immune trajectories towards severe vs non-severe adverse events.
aacrjournals.org/cancerimmuno...
We can also map out longitudinal immune trajectories towards severe vs non-severe adverse events.
aacrjournals.org/cancerimmuno...
Abstract A002: Comprehensive blood profiling for immunotherapy outcome prediction and longitudinal immune trajectory characterisation
AbstractBackground:. Immune checkpoint inhibition (ICI) has revolutionised cancer care, but many patients do not mount anti-tumor activity and most develop autoimmune toxicity. Mechanisms and risk fac...
aacrjournals.org
September 30, 2025 at 7:42 AM
We use ultra high dimensional spectral cytometry coupled with machine learning assisted analytics to generate immune signatures predictive of IO outcomes.
We can also map out longitudinal immune trajectories towards severe vs non-severe adverse events.
aacrjournals.org/cancerimmuno...
We can also map out longitudinal immune trajectories towards severe vs non-severe adverse events.
aacrjournals.org/cancerimmuno...
Check out our abstract here eppro01.ativ.me/appinfo.php?... #AACRIO25
AACR IO 2025 Conference Guide
eppro01.ativ.me
February 26, 2025 at 10:00 PM
Check out our abstract here eppro01.ativ.me/appinfo.php?... #AACRIO25